Comparison of 2-dimensional and 3-dimensional acquisition for 18F-FDG PET oncology studies performed on an LSO-based scanner
- PMID: 16391183
Comparison of 2-dimensional and 3-dimensional acquisition for 18F-FDG PET oncology studies performed on an LSO-based scanner
Abstract
Three-dimensional (3D) PET acquisition has the potential to reduce image noise but the advantage of 3D PET for studies outside the brain has not been well established. To compare the performance of 2-dimensional (2D) and 3D acquisition for whole-body (18)F-FDG applications, a series of patient studies were performed using a lutetium oxyorthosilicate (LSO)-based tomograph.
Methods: Comparative 2D and 3D images were acquired for 27 oncology patients using an LSO-based tomograph. Data acquisition (350-650 keV, 6 ns) started 99 +/- 12 min (mean +/- SD) after injection of 624 +/- 76 MBq (18)F-FDG. Bias caused by tracer redistribution and decay was eliminated by acquiring dynamic data over a single-bed position using a protocol that alternated between septa-in and septa-out modes (2D, 3D, 2D, 3D, 2D, 3D). Frames were combined to form 8 statistically independent sinograms: four 2D replicates (105 s) and four 3D replicates (90 s). The different frame durations in 2D and 3D compensated for the different number of overlapping bed positions required for an 85-cm whole-body study. Images were reconstructed with either 2D or fully 3D ordered-subsets expectation maximization (2 iterations and 8 subsets; 2D 6-mm gaussian, 3D 5- and 6-mm gaussian). Image target-to-background ratio was assessed by dividing the lesion maximum by the mean within a neighboring background region. Image noise was assessed by applying background regions of interest to the replicate images and calculating the within-patient coefficient of variation.
Results: The difference in target-to-background ratio between the 2D and 3D images, when they were filtered with 6-mm and 5-mm gaussian filters, respectively, was not highly statistically significant (P = 0.16). The mean ratio of 3D to 2D image values was 0.94 with 95% limits of agreement of 0.63-1.41. The within-patient coefficients of variation for the 2D and 3D images were 13% +/- 15% and 9% +/- 10%, respectively (P = 0.0005).
Conclusion: Under conditions of matched target to-to-background ratios, the 3D mode was found to produce images with significantly less variability than the 2D mode. These data provide support for the use of 3D acquisition with LSO detectors to reduce scan times in whole-body (18)F-FDG applications.
Similar articles
-
A lesion detection observer study comparing 2-dimensional versus fully 3-dimensional whole-body PET imaging protocols.J Nucl Med. 2004 Apr;45(4):714-23. J Nucl Med. 2004. PMID: 15073270
-
Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera.Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):1615-9. doi: 10.1007/s00259-003-1317-8. Epub 2003 Sep 23. Eur J Nucl Med Mol Imaging. 2003. PMID: 14504831
-
Impact of acquisition geometry, image processing, and patient size on lesion detection in whole-body 18F-FDG PET.J Nucl Med. 2007 Dec;48(12):1951-60. doi: 10.2967/jnumed.108.007369. Epub 2007 Nov 15. J Nucl Med. 2007. PMID: 18006613
-
Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.J Nucl Med. 2015 Apr;56(4):552-9. doi: 10.2967/jnumed.114.142596. Epub 2015 Feb 26. J Nucl Med. 2015. PMID: 25722452 Review.
-
An update on novel quantitative techniques in the context of evolving whole-body PET imaging.PET Clin. 2015 Jan;10(1):45-58. doi: 10.1016/j.cpet.2014.09.004. Epub 2014 Nov 22. PET Clin. 2015. PMID: 25455879 Review.
Cited by
-
Real time dynamic imaging and current targeted therapies in the war on cancer: a new paradigm.Theranostics. 2013 May 25;3(6):437-47. doi: 10.7150/thno.5658. Print 2013. Theranostics. 2013. PMID: 23781290 Free PMC article. Review.
-
PET/MR imaging of inflammation in atherosclerosis.Nat Biomed Eng. 2023 Mar;7(3):202-220. doi: 10.1038/s41551-022-00970-7. Epub 2022 Dec 15. Nat Biomed Eng. 2023. PMID: 36522465 Review.
-
Putting 'clear' into nuclear medicine: a decade of PET/CT development.Eur J Nucl Med Mol Imaging. 2006 Aug;33(8):857-61. doi: 10.1007/s00259-006-0137-z. Eur J Nucl Med Mol Imaging. 2006. PMID: 16794821 No abstract available.
-
Time-related study on external exposure dose of 2-deoxy-2-[F-18]fluoro-D-glucose PET for workers' safety.Radiol Phys Technol. 2020 Mar;13(1):98-103. doi: 10.1007/s12194-019-00548-0. Epub 2019 Dec 12. Radiol Phys Technol. 2020. PMID: 31832908
-
Accuracy of 3D acquisition mode for myocardial FDG PET studies using a BGO-based scanner.Eur J Nucl Med Mol Imaging. 2007 Sep;34(9):1439-46. doi: 10.1007/s00259-007-0367-8. Epub 2007 Feb 27. Eur J Nucl Med Mol Imaging. 2007. PMID: 17333179
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous